Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : The thread of life -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (1078)	8/23/2006 1:47:01 PM
From: Mike McFarland	Read Replies (2) \| Respond to of 1336

aav wouldn't have caught my eye but for the fact that Engelhardt wrote the catchy intro article--TGEN has a relationship with his lab...but he is not on the paper itself. With a MC of less than $20M, you would think Amgen would put an end to their suffering and make a lowball offer, put an end to any conflict over TNFR (tgen was sorta spun out of imnx). Nigel--thanks for the video, I finally had a look and it was worth the dial-up download time here at home, ha!